A
Amylyx Pharmaceuticals (AMLX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Amylyx Pharmaceuticals (AMLX)
Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapies for treatment paradigm for amyotrophic lateral sclerosis (ALS), and range of neurodegenerative diseases by keeping neurons alive. The Comp... Read more
- USD3.98
- USD4.18
- USD3.96
- USD19.95
- -22.60%
- 196M
- 550.92k
- 783.42k
- 282M
- 1.58
- -70.70%
Stock News
2 hours ago
There's Been No Shortage Of Growth Recently For Golden Ocean Group's (NASDAQ:GOGL) Returns On Capital
Yahoo
2 hours ago
Is Mobileye (MBLY) Ready to Change the Future of Driving?
Yahoo
3 hours ago
Congress passed the Social Security Fairness Act. Millions of people could see more in benefits as a result.
MarketWatch
5 hours ago
Manhattan Associates' (NASDAQ:MANH) five-year total shareholder returns outpace the underlying earnings growth
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
